New hope for stubborn heart failure swelling?
NCT ID NCT06285760
Summary
This study is testing if adding a drug called acetazolamide helps hospitalized heart failure patients who still have significant fluid buildup despite receiving standard diuretic medications. Researchers will measure how much extra salt and fluid patients' bodies release over 24-48 hours after receiving the added drug. The goal is to find better ways to manage dangerous fluid overload during a heart failure hospitalization.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Julia González González
RECRUITINGMadrid, 28222, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.